Literature DB >> 33672248

Abdominal Wall Defects-Current Treatments.

Isabella N Bielicki1, Stig Somme2, Giovanni Frongia3, Stefan G Holland-Cunz1, Raphael N Vuille-Dit-Bille1.   

Abstract

Gastroschisis and omphalocele reflect the two most common abdominal wall defects in newborns. First postnatal care consists of defect coverage, avoidance of fluid and heat loss, fluid administration and gastric decompression. Definitive treatment is achieved by defect reduction and abdominal wall closure. Different techniques and timings are used depending on type and size of defect, the abdominal domain and comorbidities of the child. The present review aims to provide an overview of current treatments.

Entities:  

Keywords:  abdominal wall defect; gastroschisis; omphalocele; treatment

Year:  2021        PMID: 33672248     DOI: 10.3390/children8020170

Source DB:  PubMed          Journal:  Children (Basel)        ISSN: 2227-9067


  3 in total

Review 1.  Difficulties in Diagnosing Extraperitoneal Ureteroinguinal Hernias: A Review of the Literature and Clinical Experience of a Rare Encounter in Acute Surgical Care Settings.

Authors:  Catalin Pirvu; Stelian Pantea; Alin Popescu; Mirela Loredana Grigoras; Felix Bratosin; Andrei Valceanu; Tudorel Mihoc; Vlad Dema; Mircea Selaru
Journal:  Diagnostics (Basel)       Date:  2022-01-29

2.  Current Challenges in the Treatment of the Omphalocele-Experience of a Tertiary Center from Romania.

Authors:  Elena Ţarcă; Elena Cojocaru; Laura Mihaela Trandafir; Alina Costina Luca; Răzvan Călin Tiutiucă; Lăcrămioara Ionela Butnariu; Claudia Florida Costea; Iulian Radu; Mihaela Moscalu; Viorel Ţarcă
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

Review 3.  Nursing Care Plan for a Newborn with the Defect of Congenital Gastroschisis in the Postoperative Period Using ICNPTM and the Dedicated Software.

Authors:  Paulina Szydłowska-Pawlak; Olga Barszczewska; Izabela Sołtysiak; Barbara Librowska; Remigiusz Kozlowski; Per Engleseth; Michał Marczak; Dorota Kilańska
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.